Anthracyclines have been a mainstay of breast cancer therapy for decades, with strong evidence demonstrating their impact on breast cancer survival. Apart from the proven efficacy, associated toxicity has raised concern on the use of anthracyclines and turned the spotlight on anthracycline-free regimens.
This presentation will review the role of anthracyclines in treatment of early breast cancer and share insights on anthracycline-free regimen based on clinical evidence.

Sanofi Taiwan Co., Ltd.

賽諾菲股份有限公司

賽諾菲股份有限公司

賽諾菲在台灣的主要產品是由本公司醫藥代表進行銷售，部分產品交由經銷商代理銷售。
賽諾菲台灣總部設在台北，涵蓋了主要的行政部門，為病患和醫藥領域的專業人士提供多元化治療領域的服務。
賽諾菲台灣不僅承諾為病患提供有效可靠的藥物，同時也期望能藉此能改善他們的生活品質。